MDS Virtual Congress 2020 Archives - Page 59 of 149

Daily Time-Course of Efficacy of Continuous Subcutaneous Infusion of Foslevodopa/foscarbidopa in Advanced Parkinson’s Disease Patients from a Phase 1b Study

S. Stodtmann, M. Rosebraugh, W. Robieson, M. Facheris (North Chicago, IL, USA)
De novo impulse control disorder after globus pallidus internus deep brain stimulation in a patient with myoclonus-dystonia syndrome

S. Parreira, L. Kauppila, M. Coelho (Lisboa, Portugal)
De-novo ß-actin mutation as a cause of seemingly sporadic dystonia-deafness syndrome responsive to deep-brain stimulation

N. Schell, J.K Krauss, A. Saryyeva, C. Klein, N. Brüggemann (Luebeck, Germany)
Decline in the midbrain-to-pons ratio over one year can support the differentiation between PSP and IPD

S. Kannenberg, L. Dinkelbach, J. Caspers, A. Moldovan, S. Ferrea, M. Südmeyer, M. Butz, A. Schnitzler, C. Hartmann (Düsseldorf, Germany)
Decreased Availability of Adenosine 2A Receptors in the Caudate in Patients with Early Stage Parkinson’s Disease

I. Waggan, E. Rissanen, J. Tuisku, J. Joutsa, S. Helin, R. Parkkola, J. Rinne, L. Airas (Turku, Finland)
Decreased Regional Cholinergic Signaling in Parkinson’s Disease

J. O'Donnell, Y. Zhou, M. Campbell, S. Mansor, B. Maiti, Z. Tu, J. Perlmutter (Saint Louis, MO, USA)
Deep Brain Stimulation (DBS) for Childhood Onset Dystonia

D. Munoz, M. Troncoso, D. Aguirre, E. Zambrano, R. Zepeda, S. Monsalve, R. Catalan, V. Naranjo, I. Ruiz, M. Hidalgo (Santiago, Chile)
Deep brain stimulation and cognitive decline in Parkinson’s disease: The predictive value of Alternate Fluency test

R. Ferrucci, F. Mameli, F. Ruggiero, M. Reitano, S. Marceglia, M. Massei, L. Borellini, F. Cogiamanian, T. Bocci, M. Locatelli, S. Barbieri, A. Averna, A. Priori (Milan, Italy)
Deep Brain Stimulation as the Only Advanced Therapy Available in the Dominican Rebublic, Report ot Two Cases in Centro Cardio Neuro Oftalmologico Y Transplante (Cecanot)

R. Cruz, A.A Perez (Santo Domingo, Dominican Republic)
Deep brain stimulation for generalized dystonia

K. Szalecki, T. Kmiec, H. Koziara, T. Mandat (Warszawa, Poland)
Deep Brain Stimulation for medically refractory tremor syndromes

A. Macerollo, D. Bhargava, B. Hammersley, J. Somerset, J. Osman-Farah (Liverpool, United Kingdom)
Deep Brain Stimulation impact on Social and Occupational Function in Parkinson’s Disease with Early Motor Complications

V. Stoker, P. Krack, L. Tonder, A. Schnitzler, J.L Houeto, J. Rau, C. Schade-Brittinger, M. Vidailhet, G. Deuschl (Minneapolis, MN, USA)
Deep brain stimulation in Parkinson’s disease: Selection criteria, post-surgery improvement and complications

F. Aziouaz, T. Dellal, Y. Mebrouk (Oujda, Morocco)
Deep brain stimulation in the treatment of camptocormia in Parkinson’s disease

Y. Lai, Y. Song, D. Su, L. Wang, C. Zhang, B. Sun, D. Li (Shanghai, China)
Deep brain stimulation in two patients with immunosuppressive therapy

P. Dorin, J. Walch, M. Krüger, D. Brogle, G. Kägi, S. Mittas, S. Bohlhalter, S. Hägele-Link, F. Brugger (St. Gallen, Switzerland)
Deep brain stimulation lead position impact on parkinsonian non-motor symptoms

J. Bardoň, S. Kurčová, M. Chudáčková, P. Otruba, D. Krahulík, M. Nevrlý, P. Kaňovský, J. Zapletalová, J. Valošek, P. Hluštík (Olomouc, Czech Republic)
Deep brain stimulation lead removal in Tourette syndrome: Data from the International Tourette DBS Registry and Database

W. Deeb, J. Wong, A. Leentjens, A. Mogilner, D. Servello, F. Meng, J. Zhang, T. Galbiati, M. Okun (Gainesville, FL, USA)
Deep brain stimulation peri-lead edema: Common or uncommon complication?

M. Nevrlý, P. Otruba, J. Bardoň, D. Krahulík, P. Kaňovský (Olomouc, Czech Republic)
Deep brain stimulation revision from VIM to VIM and PSA severe long-standing refractory ET: case series

S. Aslam, F. Ponce, H. Shill, J. Chan, S. Barbu, M. Lambert, G. Moguel-Cobos (Phoenix, AZ, USA)
Deep Brain Stimulation using Asymmetrical Targets in Rapid-onset Dystonia Parkinsonism (RDP)

J.N Ong, J. Shin, H.J Kim, S.H Paek, B. Jeon (Seoul, Republic of Korea)
Deep learning approach for Parkinson’s disease classification from facial expressions: A pilot feasibility study

O. Phokaewvarangkul, P. Vateekul, D. Surangsrirat, R. Bhidayasiri (Bangkok, Thailand)
Deep learning-based automatic nigrosome 1 segmentation on 3T susceptibility-weighted MRI

J.M Kim, J.H Choi, Y.J Bae, B.S Choi, Y.H Park, I.D Yun (Seongnam, Republic of Korea)
Deep phenotyping of Parkinson’s disease: a longitudinal study using multiple digital sensors

E. Waddell, S. Jensen-Roberts, T. Myers, M. Coffey, K. Lizarraga, E. Dorsey, C. Tarolli, J. Adams, R. Schneider (Rochester, NY, USA)
Deficient Balance Mechanisms during Walking in People with Parkinson’s Disease

M. Arcodia, D. Grenet, E. Thompson, H. Reimann, T. Fettrow, J. Jeka (Newark, DE, USA)
Defining time and anatomical specificity of basal ganglia white matter loss in premanifest Huntington’s disease

P. Zeun, P. McColgan, T. Dhollander, S. Gregory, E. Johnson, M. Papoutsi, R. Scahill, G. Rees, S. Tabrizi (London, United Kingdom)
Delayed lesion adverse effects of gamma knife radiosurgical thalamotomy for essential tremor

A. Patel, J. Gerrard (New Haven, CT, USA)
Delayed resolution of hemifacial spasm following suboccipital craniectomy in a patient with Arnold Chiari malformation type I

M. Elkasaby, W. Selman, S. Gunzler (Cleveland, OH, USA)
Demographic characteristics of in-hospital deaths among patients with Parkinson’s disease

O. Phillips, Z. Kunicki, U. Ackbar, R. Jones, A. D’Abreu, J. Friedman (Providence, RI, USA)
Demonstrating the clinical value of MANAGE-PD tool in assessing symptom control of Parkinson’s disease patients: Evidence from G7 countries

A. Antonini, P. Odin, A. Alobaidi, F. Cubillos, P. Schmidt, Y. Jalundhwala, K. Onuk, J. Zamudio, P. Kukreja, E. Jones, J. Wright, H. Fernandez (North Chicago, IL, USA)
Dendritic cells and brain metabolites in Tourette’s

M. Sarchioto, F. Morgante, F. Howe, I. Dumitriu, J. Stern, M. Edwards, D. Martino (London, United Kingdom)
Deposition of phosphorylated α-synuclein in the muscularis externa of the gastrointestinal tract in patients with prodromal Parkinson’s disease

G. Beck, H. Mochizuki (Suita, Japan)
Depression in Parkinson’s Disease: perspectives from an Australian cohort

M. Lubomski, R. Davis, C. Sue (Sydney, Australia)
Depression in patients with Parkinson’s disease

M. Lisak, B. Špiljak (Zagreb, Croatia)
Depression in various forms of parkinsonism and striatal hyperkinesis

R. Matmurodov, K.h Khalimova, E. Abduqodirov (Tashkent, Uzbekistan)
Detecting Lower Extremity Ataxia: Toe-Heel Tap is the Best Screening Tool

E. Smith, D. Whitney, D. Bhatti, A. Hellman, D.J Bertoni, D. Torres-Russotto (Omaha, NE, USA)
Detection of alpha-synuclein aggregation from submandibular and esophageal tissue of patients with synucleinopathies

T. Yamasaki, T. Sudhakar, E. Ostrakhovitch, E. Song (Lexington, KY, USA)
Detection of Cognitive Changes in Premanifest Huntington’s disease Using the Repeatable Battery for the Assessment of Neuropsychological Status

A. Mustafa, J. Corey-Bloom, H. Smith, J. Castleton, P. Gilbert (San Diego, CA, USA)
Determinants of quality of life in a large, online cohort of patients with Parkinson’s disease

M. Bock, E. Brown, C. Tanner (San Francisco, CA, USA)
Determination of freezing of gait with wearable sensors in patients with Parkinson’s disease

U. Eliiyi, P. Keskinoglu, T. Kahraman, A. Özkurt, B. Yürdem, G. Duran, B. Dönmez Colakoglu, A. Genc (Izmir, Turkey)
Determination of non-motor symptoms in Parkinson’s disease in Kazakhstan (on the example of the city of Almaty)

A. Aralbayeva, A. Kondybaeva, S. Kamenova, K. Kuzhibaeva (Almaty, Kazakhstan)
Deutetrabenazine for Huntington’s disease chorea—A Single Center’s Experience

D. Fischer, R. Caskey, M. Dean, V. Sung (Birmingham, AL, USA)
Deutetrabenazine Reduces Involuntary Movements in Patients Most Severely Impacted by Tardive Dyskinesia in a 3-year Open-Label Extension Trial

J. Bona, H. Barkay, A. Wilhelm, N. Chaijale, M. Gordon (Atlanta, GA, USA)
Developing A Novel Disease-Specific Psychosis Severity Scale in Parkinson’s disease (Psy-PD): A Pilot Study

Y.M Wan, E.K Tan, D. Aarsland, T.S Lee, Y.L Lo, SKS. Ting, P. Martinez-Martin, K.R Chaudhuri (London, United Kingdom)
Development and Characterization of an Ultrasensitive Assay Platform for Detection of PD Associated alpha-Synuclein Oligomers in Human Blood

D. Robakis, A. Chiu, B. Chang, R. Rubenstein (Brooklyn, NY, USA)
Development and validation of a proﬁle of peripheral immune biomarkers for Parkinson’s disease: A multicenter, retrospective study

Y. Li, J. Liu (Shanghai, China)
Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT-10)

J. Vizcarra, A. Merola, D. Torres-Russotto, G. Stebbins, A. Wagle Shukla, A. Hassan, L. Marsili, J. Krauss, R. Elble, G. Deuschl, A. Espay (Atlanta, GA, USA)
Development of a time-to-event endpoint for use in premanifest Huntington’s disease (HD) clinical trials

S. Rossomanno, H. Guthrie, E.J Wild, S.A Schobel, L. Boak, D. Trundell (Basel, Switzerland)
Development of Hypertrophic Olivary Degeneration Following Pontine Hemorrhage

K. Bird, M.H Saint-Hilaire, G. Curiale, S. O'Shea (Boston, MA, USA)
Development of novel treatment strategies for SGCE dystonia using patient-derived induced pluripotent stem cells (iPSCs)

S. Staege, A. Kutschenko, P. Seibler, K. Grütz, A. Hermann, F. Wegner (Hannover, Germany)
Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism

B. Heim, S. Mangesius, F. Krismer, A. Hussl, G.K Wenning, E.R Gizewski, M. Schocke, W. Poewe, K. Seppi (Innsbruck, Austria)
Diagnostic Demography of the Ataxia Unit at UNIFESP: 12 years experience

B. Massuyama, M. Gama, F. Abrantes, F. Filho, F. Maggi, R. Salomao, J. Freitas, S. Costa, I. Raslan, G. Diaferia, P. Matos, V. Ciarlariello, C. Jaques, M. Moraes, J. Pedroso, O. Barsottini (Sao Paulo, Brazil)
Diagnostic utility of cerebrospinal fluid t-tau/p-tau181 in Parkinson’s disease with mild cognitive impairment: A cross-sectional study in Chinese cohort

P. Zhang, Y. Li, L.J Wang, Y.H Zhang (Guangzhou, China)
Diagnostic value of olfactory dysfunction in Parkinson’s disease

K. Stepanchenko, V. Marchenko, A. Zhidkova (Kharkiv, Ukraine)
Diagnostic value of vagus nerve ultrasound in Parkinson’s disease

M. Abo Srea, N.A Kishk, R. Soliman, A. Alsayyad, M. Oraby (Beni-Suef, Egypt)
Dietary and Plasma Polyunsaturated Fatty Acids in Parkinson’s Disease

D. Yoo, Y. Lim, T. Ahn (Seoul, Republic of Korea)
Dietary insights of Parkinson’s Disease patients

N. Palavra, M. Lubomski, V. Flood, R. Davis, C. Sue (St Leonards, Australia)
Difference in distribution between alpha-synuclein oligomers and Lewy bodies in Parkinson’s disease brain

H. Sekiya, H. Kowa, Y. Hashimoto, M. Takata, R. Matsumoto, T. Toda (Kobe, Japan)
Difference in olfactory impairment between tremor dominant and akinetic rigid dominant Parkinson’s disease patients

P. Solla, C. Masala, P. Raffaella, S. Dagostino, T. Ercoli, G. Defazio (Monserrato, Italy)
Difference in pallidal single unit activity in cervical dystonia with jerky and sinusoidal head tremor

A. Sedov, S. Usova, U. Semenova, A. Gamaleya, A. Tomskiy, H. Jinnah, A. Shaikh (Moscow, Russian Federation)
Differences in subthalamic oscillatory neuronal activity associated with severity in Parkinson’s disease

P. Zhuang, M. Hallett, X. Zhao, Y. Wen, Y. Zhang, J. Li, Y. Li (Beijing, China)
Differential burden of comorbidities for Huntington’s Disease, Parkinson’s Disease and the general population for patients and care partners in the US

A. Exuzides, J. Matos, B. Ricker, D. Bega (South San Francisco, CA, USA)
Differential Diagnosis Between Functional Facial Spasm and Hemifacial Spasm: Role of Blink Reflex

V. Oppo, G. Cossu, J. Valls-Solé, M. Edwards, F. Morgante (Cagliari, Italy)
Differential Effect of Dorsal and Ventral STN Stimulation on Perseveration and Evidence Accumulation

L.B Wang, X. Qiu, A. Mandali, R. Zhu, T. Wang, C-C. Zhang, D.Y Li, V. Voon (Shanghai, China)
Differential impact of Lewy body disease and Alzheimer’s disease neuropathology on cognition

S. Ryman, M. Yutsis, L. Tian, V. Henderson, T. Montine, D. Salmon, D. Galasko, K. Poston (Stanford, CA, USA)
Differential patterns of gray matter volume in responders and non-responders with Parkinson’s disease after deep brain stimulation

Y. Lai, P. Huang, C. Zhang, T.o Wang, B. Sun, D. Li (Shanghai, China)
Differentiating Parkinson’s disease dementia and mild cognitive impairment from idiopathic Parkinson’s disease using machine learning approach

A. Bhattacharya, N. Kamble, A. S, V. N, A. Stezin, S. Hegde, A. J, R. Yadav, P. Pal (Bengaluru, India)
Diffusion Magnetic Resonance Imaging with Neurite Orientation and Dispersion Imaging (NODDI) Detects Early Localized Cortex Disruption in Parkinson’s Disease

W. Sweidan, N. Seraji-Bozorgzad, J. Stanley, E. George (Detroit, MI, USA)
Direct Targeting of the VIM Nucleus during High Intensity Focused Ultrasound (HIFU) by Direct Visualization

Z. Zibly, S. Israeli Korn (Ramat Gan, Israel)
Directional programming in GPi-DBS for Parkinson’s disease and retrospective assessment of UPDRS III outcomes: First clinical case series

H. Leal Bailey, J. Donnelly, S. Pallavaram, J. Ramirez Castaneda (San Antonio, TX, USA)
Directional versus conventional subthalamic deep brain stimulation for advanced Parkinson’s disease: Short-term outcomes of a pilot study

A. Gamaleya, A. Poddubskaya, S. Omarova, A. Tomskiy (Moscow, Russian Federation)
Directional versus Omnidirectional Deep Brain Stimulation: Results of a Multicenter Prospective Blinded Crossover Study

A. Schnitzler, P. Mir, M.A Brodsky, L. Verhagen, S. Groppa, R. Alvarez, A. Evans, M. Blazquez, S. Nagel, W. Libionka, J. Pilitsis, M. Pötter-Nerger, W. Tse, L. Almeida, N. Tomycz, J. Jimenez-Shahed, F. Carrillo, C.J Hartmann, S.J Groiss, F. Defresne, E. Karst, B. Cheeran, J. Vesper (Plano, TX, USA)
Discharge rate dependency of bursting of pallidal neurons underlying choreic movements

T. Hashimoto, T. Goto, K. Yoshida, L. Johnson, J. Vitek (Matsumoto, Japan)
Disconnected brain in functional movement disorders with anxious & depressive symptoms

F. Růžička, R. Jech, K. Mueller, M. Slovák, Z. Forejtová, T. Serranová (Prague, Czech Republic)
Discriminating Essential and Dystonic Tremor using Video-based Time Series Analysis

R. Stark, P. Fischer (Tübingen, Germany)
Discrimination of alpha-synuclein strains and sub-strains in Synucleinopathies

M. Shahnawaz, A. Mukherjee, S. Pritzkow, N. Dinamarca, F. Wang, P. Rabadia, C. Soto (Houston, TX, USA)
Disease progression characterized by motor performance, dopaminergic neurodegeneration and T cell infiltration in the transgenic hm2-α-SYN-39 mouse model of Parkinson´s disease

J. Behnke, L. Rauschenberger, S. Knorr, J. Volkmann, C.W Ip (Wuerzburg, Germany)
Disease stage and UMSARS progression: Implications for clinical trials

M. Pérez, J.A Palma, L. Norcliffe-Kaufmann, P. Millar Vernetti, W. Singer, P. Low, M.T Pellecchia, H.J Kim, C. Shibao, A. Peltier, I. Biaggioni, D. Giraldo, M.J Martí, A. Fanciulli, C. Terroba-Chambi, M. Merello, D. Goldstein, R. Freeman, C. Gibbons, S. Vernino, F. Krismer, G. Wenning, H. Kaufmann (New York, NY, USA)
Disentangling postural instability-gait difficulties classification model for the prediction of cognitive impairment in de novo Parkinson’s Disease patients

D. Urso, V. Leta, L. Batzu, T. Yousaf, C. Farrell, D. van Wamelen, R. Chaudhuri (London, United Kingdom)
Disparities in access to care and research participation among individuals with advanced Parkinson’s Disease: Comparison of participants in a home visit model vs. national registry

J. Fleisher, E. Klostermann, E. Myrick, D. Mitchem, J. Lee, K. Woo, B. Ouyang, N. Witek, J. Beck, D. Hall, J. Chodosh (Chicago, IL, USA)
Disrupted functional brain connectome at the early non-freezing stage of Parkinson’s disease patients with freezing of gait

N. Li, X. Suo, J. Zhang, D. Lei, L. Wang, J. Li, J. Peng, L. Duan, C. Chen, Q. Gong, R. Peng (Chengdu, China)
Distinct compensatory and maladaptive wiring patterns in genotypic Parkinson’s disease

K. Schindlbeck, A. Vo, N. Nguyen, A. Rommal, C. Tang, M. Niethammer, V. Dhawan, R. Saunders-Pullman, S. Bressman, D. Eidelberg (New York, NY, USA)
Distinct maladaptive and compensatory wiring patterns in penetrant and non-penetrant dystonia mutation carriers

A. Vo, K. Schindlbeck, N. Nguyen, A. Rommal, M. Niethammer, D. Eidelberg (Manhasset, NY, USA)
Distribution of intranasal hNSCs in a mouse model of MPTP-induced Parkinson’s disease

F. Wang, Y.T Zhang, S.Z Wei, C. Ren, C.F Liu (Suzhou, China)
Diverse Phenotypic Variations Among Siblings with NBIA: A Case Report and Review of Literature

N. Merghany, A. Al Hasany (Cairo, Egypt)
DJ1 and α-Synuclein as CSF biomarkers and gene polymorphisms: association with clinical parameters in Parkinson’s disease

T. Syed, T. SD, R. Kandadai, V. Kutala, R. Borgohain (Hyderabad, India)
Do dreams tell the future? Dream content analysis as a predictor of cognitive deterioration in Parkinson’s Disease

P. Bugalho, F. Ladeira, R. Barbosa, J. Marto, C. Borbinha, L. Conceição, M. Saraiva, M. Salavisa, B. Meira, M. Fernandes (Lisboa, Portugal)
Do improvements to primary symptoms from sensory training differ in Parkinson’s disease ON vs. OFF dopaminergic medications?

K. Sangarapillai, B. Norman, E. Beck, Q. Almeida (Waterloo, ON, Canada)
Does “5-2-1” identify patients with suspected Advanced Parkinson’s Disease? Evidence of clinical accuracy from G7 countries

A. Antonini, P. Odin, T. Henriksen, M. Soileau, R. Rodriguez-Cruz, A. Alobaidi, Y. Jalundhwala, P. Kandukuri, J.C Parra, K. Onuk, P. Kukreja, A. Gillespie, J. Pike, K.R Chaudhuri (North Chicago, IL, USA)
Does age at onset of Parkinson’s disease affect the development of dementia?

P. Soliveri, F. Del Sorbo, A. Zecchinelli, G. Sacilotto, N. Meucci, M. Zini, C. Mariani, S. Tesei, G. Pezzoli (Milan, Italy)
Does constipation predict cognitive impairment and dementia in de novo Parkinson’s disease patients? A multi-cohort longitudinal data analysis

V. Leta, D. Urso, L. Batzu, D. Weintraub, D. Aarsland, D. van Wamelen, T. Yousaf, P. Martinez-Martin, C. Rodriguez-Blazquez, A. Rizos, K. Ray Chaudhuri (London, United Kingdom)
Donepezil for mild cognitive impairment in Parkinson’s disease: A 48-week follow-up study

K. Baik, S. Kim, S. Kang, Y. Sohn, P. Lee, S. Kang (Seoul, Republic of Korea)
Dopaminergic denervation in de-novo Parkinson’s disease. Does functional somatotopy plays a role?

J.A Pineda-Pardo, A. Sánchez-Ferro, M. HM Monje, J.A Obeso (Móstoles, Spain)
Dose Optimization of Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients with Parkinson’s Disease: Clinical and Exposure Response Findings

F. Stocchi, C. Olanow, E. Peckham, F. Agbo, Y. Chiu, K. Sciarappa, B. Navia (Rome, Italy)
Downbeat nystagmus and progressive ataxia mimicking a neurodegenerative disease: a specific phenotype of Chiari malformation

B. Massuyama, F. Filho, J. Pedroso, O. Barsottini (Sao Paulo, Brazil)
Driving in Parkinson’s Disease: A Retrospective Study of Driving and Mobility Assessments

K. Lloyd, D. Gaunt, V. Haunton, R. Skelly, H. Mann, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)
Driving motor rhythms modulates bradykinesia and cortical excitability in Parkinson’s disease

A. Guerra, M. Bologna, D. Colella, M. Giangrosso, A. Cannavacciuolo, G. Paparella, A. Suppa, A. Berardelli (Pozzilli, Italy)
Dry Eye and Parkinson’s Disease: A Literature Review

S. Yaisawang, N. Kasetsuwan, U. Reinprayoon, J. Sringean, R. Bhidayasiri, K. Pongpirul (Bangkok, Thailand)
Dual hit model of Parkinson’s disease propagation using MRI biomarkers and partial least squares path modeling

N. Pyatigorskaya, L. Yahia-Cherif, R. Valabregue, R. Gaurav, F. Gargouri, C. Ewenczyk, C. Gallea, S. Fernandez-Vidal, I. Arnulf, M. Vidailhet, S. Lehericy (Paris, France)
Duration of Effect of IncobotulinumtoxinA for the Treatment of Blepharospasm in Botulinum Toxin-naïve Subjects: Results from a Phase III Study

F. Pagan, A. Dekundy, M. Althaus, A. Scheschonka, J. Jankovic, D. Mitsikostas (Washington, DC, USA)
Dysfunction in superior frontal gyrus associated with diphasic dyskinesia in Parkinson’s disease

S. yuting, Z. kezhong (Nanjing, China)
Dyskinesia and bradykinesia severity patterns in Parkinson’s disease using a wearable sensor

D. van Wamelen, T. Bendriss-Otiko, A. Podlewska, V. Leta, C. Lazcano Ocampo, D. Trivedi, K. Ray Chaudhuri (London, United Kingdom)
Dysphasia as a novel approach for classification of speech disorders in Parkinson’s disease and other forms of neurodegeneration

E. Vasenina, O. Levin (Moscow, Russian Federation)
DystoniaNet: Neural Biomarker-Based Platform for Dystonia Diagnosis using Deep Learning

D. Valeriani, K. Simonyan (Boston, MA, USA)